Figure 3.

Mean change from baseline to week 24 in European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life (QoL) Questionnaire-Core 30 Items (QLQ-C30) scores. Only patients with measurements at both baseline and week 24 were included. EORTC QLQ-C30 global health status/QoL and functioning scales range from 0 to 100, with higher scores indicating better health-related QoL. A clinically meaningful treatment difference was defined as a 10-point improvement or 10-point worsening from baseline for global health status/QoL. BAT: best available therapy.